New study finds maternal vaccine and monoclonal antibody effective against RSV in infants Post author: Post published:January 10, 2024 Post category:uncategorized The impact and cost-effectiveness of maternal vaccination (MV) to long-acting monoclonal antibody (la-mAB) therapy. You Might Also Like Chemical genetics uncovers promising anti-COVID compounds September 25, 2024 The CDC’s test for bird flu works, but it has issues July 26, 2024 Microbial decoration enhances drug delivery specificity and safety December 29, 2023